When stratified by BRCA1/2 mutation, a similar OS was seen for the different tumor sizes, except for pT1b (97.4% 10-year OS in BRCA1 vs 82.8% in BRCA2,p = 0.049)(Table 2). This evidence concerns the gene BRCA2 and neoplasm.